Goal-oriented hypertension management: Translating clinical trials to practice

Hypertension

Volumn 40, Issue 4, 2002, Pages 464-469

  Singer, Gregory M ^a   Izhar, Munavvar ^a   Black, Henry R ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antihypertensive agents; Antihypertensive therapy; Blood pressure monitoring; Hypertension, detection and control

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ETHNOLOGY; FEMALE; HEALTH SERVICE; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MONOTHERAPY; OUTPATIENT; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CLINICAL TRIALS; DIABETES COMPLICATIONS; DRUG THERAPY, COMBINATION; FEMALE; HEALTH PLANNING GUIDELINES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ORGANIZATIONAL OBJECTIVES;

EID: 0036790755     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000035858.04434.03     Document Type: Article

References (23)

1. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2442.
2. Joffres MR, Ghadirian P, Fodor JG, Petrasouits A, Chockalingam A, Hamlet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens. 1997;10:1097-1102.
3. Colhoun HM, Dong W, Poulter NR. Blood pressure screening management and control in England: results from the health survey for England 1994. J Hypertens. 1998;16:747-752.
4. Chamontin B, Poggi L, Lang T, Menard J, Chevalier H, Gallois H, Cremier O. Prevalence, treatment, and control of hypertension in the French population: data from a survey on high blood pressure in general practice, 1994. Am J Hypertens. 1998;11:759-762.
5. Marques-Vidal P, Tuomilehto J. Hypertension awareness, treatment, and control in the community: Is the "rule of halves" still valid? J Hum Hypertens. 1997;11:213-220.
6. Franklin SS, Jacobs MJ, Wong ND, L'Italien GJ, Lupuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension. 2001;37:869-874.
7. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J, for the National Kidney Foundation Hypertension and Diabetes Executive Committee Working Group. Preserving renal function in adults with hypertension and diabetes: a consensus approach. Am J Kidney Dis. 2000;35:646-661.
8. American Diabetes Association. Clinical practice recommendations, 2001. Diabetes Care. 2001;24:S1-S133.
9. Black HR, Elliott WJ, Neaton JD, Grandits G, Grambsch P, Grimm RH Jr, Hansson L, Lacouciere Y, Muller J, Sleight P, Weber MA, White WB, Williams G, Wittes J, Zanchetti A, Fakouhi TD, Anders RJ for the CONVINCE Research Group. Baseline characteristics and early blood pressure control in the CONVINCE Trial. Hypertension. 2001;37:12-18.
10. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet. 1998;351:1755-1762.
11. Simpson JA, Weiner ESC, eds. Oxford English Dictionary, 2nd ed. Oxford: Clarendon Press, 1989.
12. Alexander M, Tekawa I, Hunkeler E, Fireman B, Rowell R, Selby JV, Massie BM, Cooper W. Evaluating hypertension control in a managed care setting. Arch Intern Med. 1999;159:2673-2677.
13. National Committee for Quality Assurance. HEDIS 2000. vol 2, Technical Specifications. Washington, DC: Committee on Performance Measurement; 1999.
14. National Committee on Quality Assurance. NCQA's State of Managed Care Quality. Report. Washington, DC: Committee on Performance Measurement; 1999, 2000.
15. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-313.
16. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, Moskowitz MA. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957-1963.
17. Swales JD. Current clinical practice in hypertension: The EISBERG (Evaluation and Interventions for Systolic Blood Pressure Elevation - Regional and Global) Project. Am Heart J. 1999;138:231-237.
18. Black HR. The paradigm has shifted to systolic blood pressure. Hypertension. 1999;34:386-387.
19. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479-486.
20. Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Biossel JP, Coope J, Ekbom T, Gueyffier F, Liu L, Kerlikowske K, Pocock S, Fagard RH. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000;355:865-872.
21. Ogden LG, He J, Lydick E, Whelton PK. Long term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension. 2000;35:534-543.
22. Materson BJ. Lessons on the interaction of race and antihypertensive drugs from the VA cooperative study group on antihypertensive agents. Am J Hypertens. 1995;8:91s-93s.
23. LaCroix AZ, Ott SM, Ichikawa L, Scholes D, Barlow WE. Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2000;133:516-526.